Entecavir Treatment is Safe and Highly Effective in the Patient with de Novo Hepatitis B Infection After Liver Transplantation: Case Report
暂无分享,去创建一个
S. Kaçar | N. Turhan | M. Akdoğan | S. Kuran | B. Bostancı | B. Kayhan | T. Oruğ | H. Gökcan
[1] R. Chung,et al. Lamivudine Compared With Newer Antivirals for Prophylaxis of Hepatitis B Core Antibody Positive Livers: A Cost‐Effectiveness Analysis , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] H. Bohorquez,et al. Liver transplantation in hepatitis B core–negative recipients using livers from hepatitis B core–positive donors: A 13‐year experience , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] J. Emond,et al. Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and Other Nucleos(t)ides: A 12-Year Experience , 2013, Transplantation.
[4] Jen-Jung Pan,et al. Low prevalence of HBV DNA in the liver allograft from anti‐HBc‐positive donors: a single‐center experience , 2011, Clinical transplantation.
[5] S. Saab,et al. Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody–positive donors: A systematic review , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] A. Burroughs,et al. Liver grafts from anti-hepatitis B core positive donors: a systematic review. , 2010, Journal of hepatology.
[7] Bao-en Wang,et al. Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy , 2009, Transplant infectious disease : an official journal of the Transplantation Society.
[8] V. Tak. CHRONIC HEPATITIS B A GUIDELINE TO DIAGNOSIS, APPROACH, MANAGEMENT, AND FOLLOW-UP 2007 TURKISH ASSOCIATION FOR THE STUDY OF LIVER , 2008 .
[9] H. Marusawa,et al. Beneficial Effects of Short‐Term Lamivudine Treatment for de novo Hepatitis B Virus Reactivation After Liver Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] J. Aranda‐Michel,et al. Case Report of Lamivudine‐Resistant Hepatitis B Virus Infection Post Liver Transplantation from a Hepatitis B Core Antibody Donor , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] M. Buti,et al. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] P. Gow,et al. De novo hepatitis B infection acquired during liver transplantation. , 2001, QJM : monthly journal of the Association of Physicians.
[13] J. Córdoba,et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti‐HBc positivity in the donor population , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] A. López-Sanromán,et al. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[15] M. Vivarelli,et al. De Novo Hepatitis B and C Viral Infection after Liver Transplantation , 1997, World Journal of Surgery.